CancerCare Manitoba, Winnipeg, Canada.
Dr. Bhubaneswar Borooah Cancer Institute, Guwahati, India.
Ann R Coll Surg Engl. 2023 Nov;105(8):739-746. doi: 10.1308/rcsann.2022.0126. Epub 2023 Feb 7.
Accurate preoperative localisation of parathyroid adenoma is imperative for the success of minimally invasive parathyroidectomy (MIP).
Our study aimed to evaluate the role of four-dimensional computer tomography (4D-CT) scan as an imaging modality in patients with failed and discordant localisation reported in the first-line imaging modalities (ultrasonography and Tc-MIBI-SPECT/CT).
This is a prospective cohort study performed at a university teaching centre from March 2013 to July 2021. All patients with primary hyperparathyroidism who had failed localisation by ultrasonography and Tc-MIBI-SPECT/CT (SpCT), or discordance between them, had 4D-CT performed in this study.
One hundred and two sporadic cases of pHPT with failed/discordant first-line imaging had 4D-CT imaging prior to parathyroidectomy. In 102 patients, 105 parathyroid adenomas were reported on histopathology. 4D-CT was able to localise 78% of them to the correct side and 64% to the correct quadrant in 102 patients, as compared with US (correct side 21%, correct quadrant 16%) and Tc-MIBI-SPECT/CT (correct side 36%, correct quadrant 31%). 4D-CT had a sensitivity, precision, accuracy and F1 score for correct quadrant localisation as 79%, 81%, 66% and 80%; and for correct side localisation as 82%, 98%, 80% and 89%, respectively. 4D-CT was able to identify three ectopic adenomas (two in superior mediastinum and one in the oesophageal wall) which were not detected on US or SpCT.
4D-CT was found to be sensitive and accurate in preoperative localising of the diseased parathyroid glands after failed/discordant US and SpCT. This led to more patients being offered MIP as the primary surgery and improved operative outcomes.
甲状旁腺腺瘤的准确术前定位对于微创甲状旁腺切除术(MIP)的成功至关重要。
我们的研究旨在评估四维计算机断层扫描(4D-CT)作为影像学手段在一线影像学(超声和 Tc-MIBI-SPECT/CT)报告定位失败和不一致的患者中的作用。
这是一项于 2013 年 3 月至 2021 年 7 月在一所大学教学中心进行的前瞻性队列研究。所有原发性甲状旁腺功能亢进症患者,超声和 Tc-MIBI-SPECT/CT(SpCT)定位失败或两者不一致,均在本研究中进行 4D-CT 检查。
102 例 pHPT 患者一线影像学检查失败/不一致,行甲状旁腺切除术前行 4D-CT 成像。在 102 例患者中,105 例甲状旁腺瘤组织病理学报告。4D-CT 能够正确定位 78%的腺瘤至正确侧,64%的腺瘤至正确象限,而超声(正确侧 21%,正确象限 16%)和 Tc-MIBI-SPECT/CT(正确侧 36%,正确象限 31%)则无法做到。4D-CT 对正确象限定位的敏感性、特异性、准确性和 F1 评分分别为 79%、81%、66%和 80%;对正确侧定位的敏感性、特异性、准确性和 F1 评分分别为 82%、98%、80%和 89%。4D-CT 能够识别出 3 例超声或 SpCT 未检出的异位腺瘤(2 例位于上纵隔,1 例位于食管壁)。
4D-CT 在超声和 SpCT 定位失败或不一致的情况下,能够敏感、准确地定位病变甲状旁腺,从而使更多患者接受 MIP 作为主要手术,并改善手术结果。